Alloutcoach Tim

In late 2024 I spoke with an academically trained cardiologist expert in cardiometabolic risk prevention and obesity medicine, educator, Dr. Eldad Einav, from Beverly Hills, CA about the ongoing controversy about the shortage and patient access to the exciting new weight loss treatments such as GLP1 agonists. He shared many practical, clinical insights and research that are important to revisit today for patients, physicians, and payers who are seeking to provide the best solutions and learn from some recent shortcomings.0:00 Highlight #1 - Distinguishing the quality of weight loss solutions1:26 Highlight #2 - Providing reliable 503B Facility source for patients w/ no access to GLP13:18 - Speaker Introduction6:14 - Why Dr. Einav decided to specialize in obesity / weight loss9:38 - Why should cardiologists focus on weight management - preventive care?11:58 - Not many cardiologists manage weight12:34 - Patient preferences to treat weight vs hypertension or cholesterol14:34 - Problem of maintaining long-term wei